Hyperemesis Gravidarum — ED Care

Key Points

• Hyperemesis gravidarum is defined by severe clinical impact, dehydration, nutritional compromise, and inability to maintain intake, not by ketonuria alone.
• Always consider alternative diagnoses when symptoms are atypical, severe, or begin later in pregnancy.
• Use isotonic fluids and replace measured electrolyte deficits.
• Give thiamine before or with dextrose in patients with prolonged vomiting or malnutrition risk.
• Pregnancy-appropriate antiemetics should be used actively; undertreatment also carries maternal and fetal risk.
• Combination antiemetic therapy is reasonable when one class is inadequate.
• Hospitalized patients require VTE risk assessment because dehydration and immobility increase thrombosis risk.
• Discharge requires a sustainable oral hydration and medication plan with obstetric follow-up.

Algorithm

1. Confirm pregnancy and assess hemodynamics, hydration, weight change, oral intake, urine output, and symptom duration.
2. Screen for abdominal, urinary, neurologic, endocrine, infectious, and obstetric red flags that suggest another diagnosis.
3. Obtain electrolytes, renal function, urinalysis, and other targeted testing according to severity; use ultrasound when pregnancy status or alternative pathology requires it.
4. Give isotonic crystalloid and correct potassium, magnesium, and other deficits.
5. Administer thiamine before or with dextrose in prolonged vomiting or malnutrition risk.
6. Start or escalate pregnancy-appropriate antiemetic therapy, combining classes when needed.
7. Reassess ability to drink, orthostatic symptoms, urine output, laboratory abnormalities, and functional status.
8. Treat reflux, constipation, or other contributors and consider nutritional support for persistent severe disease.
9. Admit or use ambulatory day-care pathways when oral treatment fails or metabolic and nutritional complications persist.
10. Arrange obstetric follow-up and a scheduled outpatient antiemetic and hydration plan.

Clinical Synopsis & Reasoning

Nausea and vomiting are common in early pregnancy, but hyperemesis gravidarum represents the severe end of the spectrum. It can produce dehydration, weight loss, electrolyte disturbance, ketosis from starvation, malnutrition, thiamine deficiency, acute kidney injury, and substantial psychosocial impairment. Current RCOG guidance emphasizes clinical severity and impact rather than relying on ketonuria as a defining marker of dehydration or disease severity.

The diagnosis requires a pregnancy-associated vomiting syndrome while considering alternative causes. Symptoms usually begin early in pregnancy. New vomiting later in gestation, severe abdominal pain, fever, diarrhea, focal neurologic findings, hypertension, jaundice, or atypical laboratory abnormalities should broaden the differential to gastroenteritis, appendicitis, biliary disease, pancreatitis, hepatitis, urinary infection, pyelonephritis, diabetic ketoacidosis, thyroid disease, intracranial disease, preeclampsia-related illness, and medication effects. Multiple gestation and gestational trophoblastic disease can intensify pregnancy-related nausea and should be considered when uterine size, beta-hCG pattern, bleeding, or ultrasound findings are atypical.

Assess volume status, orthostatic symptoms, weight change, oral intake, urine output, prior antiemetics, and functional impairment. Check for abdominal tenderness, peritoneal signs, fever, neurologic abnormalities, and pregnancy-related red flags. Thyroid tests can be abnormal because hCG can stimulate the TSH receptor; transient gestational thyrotoxicosis does not automatically require antithyroid therapy. Laboratory evaluation is targeted to severity and differential diagnosis.

The major preventable neurologic complication is Wernicke encephalopathy from thiamine deficiency. Patients with prolonged vomiting or malnutrition should receive thiamine, particularly before or with dextrose-containing fluids. Venous thromboembolism risk is increased in hospitalized patients with hyperemesis, especially when dehydration and immobility are present.

Treatment Strategy & Disposition

Restore intravascular volume with isotonic crystalloid and replace potassium or other electrolytes according to measured deficits. Avoid giving dextrose as the sole initial fluid in a thiamine-depleted patient. Give thiamine before or with carbohydrate in patients with prolonged vomiting, weight loss, malnutrition, or repeated presentations. Reassess urine output, symptoms, orthostasis, electrolytes, and ability to tolerate oral intake after treatment.

Antiemetic therapy should be active rather than withheld because of exaggerated fetal-safety concerns. RCOG guidance supports use of established pregnancy antiemetics from several classes. Options include antihistamine and phenothiazine agents, metoclopramide, and ondansetron, with choice based on prior response, gestational context, side effects, and local practice. Combination therapy from different drug classes is reasonable when monotherapy fails. Metoclopramide can cause extrapyramidal effects, and ondansetron has QT and constipation considerations. Refractory disease may require specialist-directed corticosteroids after standard therapies have failed.

If reflux or gastritis worsens symptoms, H2 blockers or proton pump inhibitors can be used when indicated. Treat constipation, which can be aggravated by dehydration and antiemetics. Nutritional support becomes important in prolonged or severe disease; enteral feeding is generally preferred over parenteral nutrition when feasible. Multidisciplinary obstetric, nutrition, and sometimes mental-health support may be required because the disease can be profoundly disabling.

Admit patients who remain unable to tolerate fluids or medications, have significant electrolyte disturbance, acute kidney injury, severe weight loss or malnutrition, recurrent syncope, concerning comorbidity, or an alternative diagnosis requiring inpatient care. Ambulatory day-care treatment can reduce admission in selected systems. Hospitalized patients should undergo VTE risk assessment and receive prophylaxis when indicated. Before discharge, provide a scheduled antiemetic plan rather than as-needed rescue alone when symptoms are persistent, and arrange obstetric follow-up.

Epidemiology / Risk Factors

• Nausea and vomiting affect a large majority of pregnancies, while hyperemesis gravidarum affects a much smaller but clinically important proportion.
• RCOG reports hyperemesis in roughly 0.3 to 3.6 percent of pregnancies depending on definition and population.
• Symptoms usually begin in the first trimester and improve by mid-pregnancy for most patients, although some have persistent disease.
• Prior hyperemesis increases recurrence risk in later pregnancies.
• Multiple gestation and molar pregnancy can be associated with more severe symptoms because of higher hCG exposure.

Investigations

Antiemetic Ladder

Pharmacology

Prognosis / Complications

• Most patients improve with fluid support, effective antiemetics, and progression of gestation.
• Repeated dehydration and malnutrition can lead to renal injury, electrolyte disturbances, thrombosis, and micronutrient deficiency.
• Wernicke encephalopathy is preventable but can cause permanent neurologic injury when thiamine deficiency is missed.
• Severe prolonged disease may be associated with reduced maternal weight gain and adverse fetal growth outcomes.
• Early individualized antiemetic plans and rapid access to hydration can reduce repeated hospital admission.

Patient Education / Counseling

• Explain that hyperemesis is a genuine medical disorder and can require repeated treatment; it is not simply ordinary morning sickness.
• Take prescribed antiemetics on the recommended schedule when symptoms are persistent rather than waiting until vomiting is uncontrollable.
• Use small frequent fluids and foods as tolerated without forcing intake during active vomiting.
• Seek urgent reassessment for fainting, inability to keep down fluids, very low urine output, confusion, severe abdominal pain, fever, blood in vomit, or new neurologic symptoms.
• Discuss medication concerns with the obstetric team rather than stopping effective therapy without an alternative plan.
• Patients with previous severe hyperemesis should discuss an early-treatment plan before or at the beginning of a future pregnancy.

Notes

The 2024 RCOG update reinforces two practical points that matter in emergency care. First, severe pregnancy vomiting should be treated actively with evidence-based antiemetics rather than minimized. Second, ketonuria is not a reliable stand-alone marker of dehydration or disease severity. The patient’s intake, weight, vital signs, renal function, electrolytes, and functional impairment are more clinically meaningful.

Thiamine is a small intervention with major preventive value. Any patient with prolonged vomiting, repeated presentations, significant weight loss, or malnutrition risk should receive thiamine before substantial carbohydrate administration.

References

1. RCOG Green-top Guideline No. 69: Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum — Link
2. RCOG 2024 Update on Hyperemesis Gravidarum — Link